Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 12, Issue SUPPL. 2, 2006, Pages

  Wakabayashi, K ^a   Mori, F ^a   Takahashi, H ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Synuclein; Lewy body; Neuromelanin; Pale body; Parkinson's disease; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; MELANIN;

CELL LOSS; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; LEWY BODY; LOCUS CERULEUS; NERVE CELL DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PIGMENTATION; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA; THALAMUS VENTRAL NUCLEUS;

EID: 33749046099     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.05.028     Document Type: Review

References (61)

1. Lewy F.H. Paralysis agitans. I. Pathologische Anatomie. In: Lewandowsky M. (Ed). Hundbuch der Neurologie III (1912), Springer, Berlin 920-933
2. Jellinger K. Overview of the morphological changes in Parkinson's disease. Adv Neurol 45 (1987) 1-18
3. Goedert M. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and α-synucleinopathies. Phil Trans R Soc Lond B Biol Sci 354 1386 (1999) 1101-1118
4. Jellinger K.A. Neuropathological spectrum of synucleinopathies. Mov Disord 18 Suppl 6 (2003) S2-S12
5. Wakabayashi K., Takahashi H., Obata K., and Ikuta F. Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease. Neurosci Lett 138 2 (1992) 237-240
6. Duffy P.E., and Tennyson V.M. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease. J Neuropathol Exp Neurol 24 3 (1965) 398-414
7. den Hartog Jager W.A., and Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23 4 (1960) 283-290
8. Ohama E., and Ikuta F. Parkinson's disease. Distribution of Lewy bodies and monoamine neurons system. Acta Neuropathol 34 4 (1976) 311-319
9. Oyanagi K., Wakabayashi K., Ohama E., Takeda S., Horikawa Y., Morita T., et al. Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease. Acta Neuropathol 80 5 (1990) 558-559
10. Kakita A., Takahashi H., Homma Y., and Ikuta F. Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson's disease. Pathol Int 44 12 (1994) 878-880
11. Wakabayashi K., and Takahashi H. The intermediolateral nucleus and Clarke's column in Parkinson's disease. Acta Neuropathol 94 3 (1997) 287-289
12. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 3 (1992) 181-184
13. Braak H., Braak E., Yilmazer D., de Vos R.A., Jansen E.N., Bohl J., et al. Amygdala pathology in Parkinson's disease. Acta Neuropathol 88 6 (1994) 493-500
14. Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76 3 (1988) 217-221
15. Takeda S., Yamazaki K., Miyakawa T., and Arai H. Parkinson's disease with involvement of the parasympathetic ganglia. Acta Neuropathol 86 4 (1993) 397-398
16. Wakabayashi K., and Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 38 Suppl 2 (1997) 2-7
17. Iwanaga K., Wakabayashi K., Yoshimoto M., Tomita I., Satoh H., Takashima H., et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52 6 (1999) 1269-1271
18. Murayama S. Systemic pathology of Lewy-related Parkinson changes in aging. The experience of Tokyo Metropolitan Brain Bank for Aging Research. In: Yamamoto M. (Ed). Parkinson's disease: advances in pathology and autonomic nervous system (2004), Chugai Igaku, Tokyo 34-45
19. Pollanen M.S., Dickson D.W., and Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52 3 (1993) 183-191
20. Polymeropoulos M.H., Lavendan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutaion in the α-synuclein gene identified in families with Parkinson's disease. Science 276 5321 (1997) 2405-2407
21. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., Rohan de Silva H.A., et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 2 (1995) 467-475
22. Spillantini M.G., Schmidt M.L., Lee V.-Y., Trojanowski J.Q., Jakes R., and Goedert M. α-Synuclein in Lewy bodies. Nature 388 6645 (1997) 839-840
23. Arima K., Uéda K., Sunohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H., et al. Immunoelectron-microscopic demonstration of NACP/α-synuclein epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808 1 (1998) 93-100
24. Conway K.A., Harper J.D., and Lansbury P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat Med 4 11 (1998) 1318-1320
25. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287 5456 (2000) 1265-1269
26. Kahle P.J., Neumann M., Ozmen L., Müller V., Odoy S., Okamoto N., et al. Selective insolubility of α-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol 159 6 (2001) 2215-2225
27. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg S., et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4 2 (2002) 160-164
28. Hasegawa M., Fujiwara H., Nonaka T., Wakabayashi K., Takahashi H., Lee V.-Y., et al. Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions. J Biol Chem 277 50 (2002) 49071-49076
29. Wakabayashi K., Engelender S., Yoshimoto M., Tsuji S., Ross C.A., and Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 47 4 (2000) 521-523
30. Dev K.K., Hofele K., Barbieri S., Buchman V.L., and van der Putten H. Part II: α-Synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45 1 (2003) 14-44
31. Mori F., Nishie M., Piao Y- S., Kito K., Kamitani T., Takahashi H., et al. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 31 1 (2005) 53-61
32. Pappolla M.A., Shank D.L., Alzofon J., and Dudley A.W. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease. Hum Pathol 19 1 (1988) 27-31
33. Gibb W.R., Scott T., and Lees A.J. Neuronal inclusions of Parkinson's disease. Mov Disord 6 1 (1991) 2-11
34. Dale G.E., Probst A., Luthert P., Martin J., Anderton B.H., and Leigh P.N. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol 83 5 (1992) 525-529
35. Takahashi H., Iwanaga K., Egawa S., and Ikuta F. Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-parkinsonian patient. Neuropathology 14 2 (1994) 73-80
36. Takahashi H., and Wakabayashi K. The cellular pathology of Parkinson's disease. Neuropathology 21 4 (2001) 315-322
37. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M., et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 96 5 (1998) 445-452
38. Saito Y., Kawashima A., Ruberu N.N., Fujiwara H., Koyama S., Sawabe M., et al. Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropathol Exp Neurol 62 6 (2003) 644-654
39. Kuusisto E., Parkkinen L., and Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62 12 (2003) 1241-1253
40. Pearson J., Goldstein M., Markey K., and Brandeis L. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8 1 (1983) 3-32
41. Takahashi H., Nakashima S., Ohama E., Takeda S., and Ikuta F. Distribution of serotonin-containing cell bodies in the brainstem of the human fetus determined with immunohistochemistry using antiserotonin serum. Brain Dev 8 4 (1986) 355-365
42. Halliday G.M., Li Y.W., Blumbergs P.C., Joh T.H., Cotton R.G., Howe P.R., et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27 4 (1990) 373-385
43. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318 14 (1988) 876-880
44. Graybiel A.M., Hirsch E.C., and Agid Y. The nigrostriatal system in Parkinson's disease. Adv Neurol 53 (1990) 17-29
45. Matzuk M.M., and Saper C.B. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann Neurol 18 5 (1985) 552-555
46. Halliday G.M., Blumbergs P.C., Cotton R.G.H., Blessing W.W., and Geffen L.B. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 510 1 (1990) 104-107
47. Gai W.P., Geffen L.B., Denoroy L., and Blessing W.W. Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease. Ann Neurol 33 4 (1993) 357-367
48. Whitehouse P.J., Hedreen J.C., White CL I.I.I., and Price D.L. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13 3 (1983) 243-248
49. Gaspar P., and Gray F. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol 64 1 (1984) 43-52
50. Tagliavini F., Pilleri G., Bouras C., and Constantinidis J. The basal nucleus of Meynert in idiopathic Parkinson's disease. Acta Neurol Scand 70 1 (1984) 20-28
51. Zweig R.M., Jankel W.R., Hedreen J.C., Mayeux R., and Price D.L. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26 1 (1989) 41-46
52. Gai W.P., Blumbergs P.C., Geffen L.B., and Blessing W.W. Age-related loss of dorsal vagal neurons in Parkinson's disease. Neurology 42 11 (1992) 2106-2111
53. Mori F., Piao Y.S., Hayashi S., Fujiwara H., Hasegawa M., Yoshimoto M., et al. α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 62 8 (2003) 812-819
54. Zecca L., Fariello R., Riederer P., Sulzer D., Gatti A., and Tampellini D. The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett 510 3 (2002) 216-220
55. Gibb W.R., and Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulation of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54 5 (1991) 388-396
56. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 5 (1991) 2283-2301
57. Gibb W.R., Narabayashi H., Yokochi M., Iizuka R., and Lees A.J. New pathologic observations in juvenile onset parkinsonism with dystonia. Neurology 41 6 (1991) 820-822
58. Takahashi H., Ohama E., Suzuki S., Horikawa Y., Ishikawa A., Morita T., et al. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44 3 (1994) 437-441
59. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E., et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. Neurobiol Aging 24 2 (2003) 197-211
60. Goldberg M.S., and Lansbury Jr. P.T. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease?. Nat Cell Biol 2 7 (2000) E115-E119
61. Zecca L., Zucca F.A., Wilms H., and Sulzer D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 26 11 (2003) 578-580